Review article: novel therapies for hepatitis B virus cure - advances and perspectives
出版年份 2016 全文链接
标题
Review article: novel therapies for hepatitis B virus cure - advances and perspectives
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 44, Issue 3, Pages 213-222
出版商
Wiley
发表日期
2016-06-15
DOI
10.1111/apt.13694
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical outcomes after spontaneous and nucleos(t)ide analogue-treated HBsAg seroclearance in chronic HBV infection
- (2016) Y. C. Chen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B-related hepatocellular carcinoma
- (2016) G. L.-H. Wong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance
- (2016) F. Liu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance
- (2016) P. P. Gounder et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg
- (2016) Chia-Chi Wang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Off-treatment durability of antiviral response to nucleoside analogues in patients with chronic hepatitis B
- (2016) Naruhiko Nagata et al. BMC GASTROENTEROLOGY
- New perspectives on the hepatitis B virus life cycle in the human liver
- (2016) Peter A. Revill et al. JOURNAL OF CLINICAL INVESTIGATION
- A Phase 3 Study of Tenofovir Alafenamide Compared with Tenofovir Disoproxil Fumarate in Patients with Hbeag-Negative, Chronic Hepatitis B: Week 48 Efficacy and Safety Results
- (2016) M. Buti et al. JOURNAL OF HEPATOLOGY
- A Phase 3 Study of Tenofovir Alafenamide Compared with Tenofovir Disoproxil Fumarate in Patients with Hbeag-Positive Chronic Hbv: Week 48 Efficacy and Safety Results
- (2016) H.L.Y. Chan et al. JOURNAL OF HEPATOLOGY
- Hepatitis B virus: new therapeutic perspectives
- (2016) Chih-Lin Lin et al. LIVER INTERNATIONAL
- Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study
- (2015) J. Ahn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection
- (2015) T.-C. Tseng et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B
- (2015) M.-L. Chang et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Implications of Efficient Hepatic Delivery by Tenofovir Alafenamide (GS-7340) for Hepatitis B Virus Therapy
- (2015) Eisuke Murakami et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent
- (2015) Robert G. Gish et al. ANTIVIRAL RESEARCH
- Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
- (2015) Tse-Ling Fong et al. DIGESTIVE DISEASES AND SCIENCES
- Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure
- (2015) Mirjam B Zeisel et al. GUT
- Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation
- (2015) Teng-Yu Lee et al. HEPATOLOGY
- AASLD guidelines for treatment of chronic hepatitis B
- (2015) Norah A. Terrault et al. HEPATOLOGY
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- Progress and Prospects of Anti-HBV Gene Therapy Development
- (2015) Mohube Maepa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: Results from a multicentre study
- (2015) Man-Fung Yuen et al. JOURNAL OF HEPATOLOGY
- The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
- (2015) Edward J. Gane et al. JOURNAL OF HEPATOLOGY
- Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance
- (2015) Gi-Ae Kim et al. JOURNAL OF HEPATOLOGY
- Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection
- (2015) Kosh Agarwal et al. JOURNAL OF HEPATOLOGY
- Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B
- (2015) Stephan Menne et al. JOURNAL OF HEPATOLOGY
- Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
- (2015) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Perspectives and control of hepatitis B virus infection in Taiwan
- (2015) Chih-Lin Lin et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR
- (2015) Michael Boettcher et al. MOLECULAR CELL
- HBV cure—can we pin our hopes on immunotherapy?
- (2015) Hung-Chih Yang et al. Nature Reviews Gastroenterology & Hepatology
- Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection
- (2015) Faseeha Noordeen et al. PLoS One
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
- (2015) JOURNAL OF HEPATOLOGY
- Tenofovir alafenamide is not a substrate for renal organic anion transporters (OATs) and does not exhibit OAT-dependent cytotoxicity
- (2014) Rujuta A Bam et al. ANTIVIRAL THERAPY
- Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection
- (2014) Maria Buti et al. DIGESTIVE DISEASES AND SCIENCES
- Strategies to eliminate HBV infection
- (2014) Rama Kapoor et al. Future Virology
- Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B—A Nationwide Cohort Study
- (2014) Chun-Ying Wu et al. GASTROENTEROLOGY
- Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
- (2014) Stephan Urban et al. GASTROENTEROLOGY
- Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
- (2014) Pauline Arends et al. GUT
- TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice
- (2014) Perrine Martin et al. GUT
- Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas
- (2014) Giuliana Amaddeo et al. GUT
- Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults
- (2014) M. Markowitz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation
- (2014) Bertram Bengsch et al. JOURNAL OF HEPATOLOGY
- Tickling the TLR7 to cure viral hepatitis
- (2014) Emily Funk et al. Journal of Translational Medicine
- Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world setting
- (2014) R. Idilman et al. JOURNAL OF VIRAL HEPATITIS
- AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication
- (2014) Nicholas D. Weber et al. PLoS One
- The Intracellular HBV DNAs as Novel and Sensitive Biomarkers for the Clinical Diagnosis of Occult HBV Infection in HBeAg Negative Hepatocellular Carcinoma in China
- (2014) Hui Wang et al. PLoS One
- Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
- (2014) J. Lucifora et al. SCIENCE
- Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: A randomized study
- (2014) Anuj Gaggar et al. VACCINE
- Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance
- (2014) Luis Menéndez-Arias et al. Current Opinion in Virology
- Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance
- (2014) Hung-Chih Yang et al. Emerging Microbes & Infections
- The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
- (2014) Su-Ru Lin et al. Molecular Therapy-Nucleic Acids
- Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B
- (2013) A. K. Singal et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Chronic hepatitis B: What should be the goal for new therapies?
- (2013) Timothy M. Block et al. ANTIVIRAL RESEARCH
- GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees
- (2013) Robert E. Lanford et al. GASTROENTEROLOGY
- Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B
- (2013) Ching-Lung Lai et al. GUT
- Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma
- (2013) Jessica Liu et al. GUT
- Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients
- (2013) Wen-Juei Jeng et al. HEPATOLOGY
- Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis
- (2013) Grace Lai-Hung Wong et al. HEPATOLOGY
- Sulfamoylbenzamide Derivatives Inhibit the Assembly of Hepatitis B Virus Nucleocapsids
- (2013) M. R. Campagna et al. JOURNAL OF VIROLOGY
- Inactivation of Hepatitis B Virus Replication in Cultured Cells and In Vivo with Engineered Transcription Activator-Like Effector Nucleases
- (2013) Kristie Bloom et al. MOLECULAR THERAPY
- Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection
- (2013) Christine I Wooddell et al. MOLECULAR THERAPY
- An Efficient Antiviral Strategy for Targeting Hepatitis B Virus Genome Using Transcription Activator-Like Effector Nucleases
- (2013) Jieliang Chen et al. MOLECULAR THERAPY
- Identification of Disubstituted Sulfonamide Compounds as Specific Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation
- (2012) Dawei Cai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues
- (2012) Carolina Boni et al. GASTROENTEROLOGY
- Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy
- (2012) Ching-Lung Lai et al. HEPATOLOGY
- Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
- (2012) Tetsuya Hosaka et al. HEPATOLOGY
- Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection
- (2012) Chun-Ying Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy
- (2012) Kevin T. Chaung et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
- (2012) Tassilo Volz et al. JOURNAL OF HEPATOLOGY
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
- (2012) Patrick Marcellin et al. LANCET
- PD-1 Blockage Reverses Immune Dysfunction and Hepatitis B Viral Persistence in a Mouse Animal Model
- (2012) Horng-Tay Tzeng et al. PLoS One
- Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
- (2012) Huan Yan et al. eLife
- Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma
- (2011) J. S.-W. Wong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Phenylpropenamide derivatives: Anti-hepatitis B virus activity of the Z isomer, SAR and the search for novel analogs
- (2011) Peiyuan Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Evolution and classification of the CRISPR–Cas systems
- (2011) Kira S. Makarova et al. NATURE REVIEWS MICROBIOLOGY
- Long-Term Nucleos(t)ide Analogues Therapy for Adults With Chronic Hepatitis B reduces the Risk of Long-Term Complications: a meta-analysis
- (2011) Qin-Qin Zhang et al. Virology Journal
- Trapping of Hepatitis B Virus Capsid Assembly Intermediates by Phenylpropenamide Assembly Accelerators
- (2010) Sarah P. Katen et al. ACS Chemical Biology
- Meta-analysis: reduction in hepatic events following interferon-alfa therapy of chronic hepatitis B
- (2010) G. L.-H. Wong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatitis B: The virus and disease
- (2010) T. Jake Liang HEPATOLOGY
- Hepatitis B e-antigen Persistency is Associated with the Properties of HBV-Specific CD8 T Cells in CHB Patients
- (2010) Guoping Peng et al. JOURNAL OF CLINICAL IMMUNOLOGY
- The molecular basis of the failed immune response in chronic HBV: Therapeutic implications
- (2010) Mala K. Maini et al. JOURNAL OF HEPATOLOGY
- Zinc-finger Nucleases as a Novel Therapeutic Strategy for Targeting Hepatitis B Virus DNAs
- (2010) Thomas J Cradick et al. MOLECULAR THERAPY
- Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
- (2009) Paola Fisicaro et al. GASTROENTEROLOGY
- Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy
- (2009) Daniel J. Tenney et al. HEPATOLOGY
- Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
- (2008) J. J. Y. SUNG et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells
- (2008) Jun Wu et al. HEPATOLOGY
- 103 VIROLOGICAL AND BIOCHEMICAL RESPONSE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B TREATED WITH PEGINTERFERON ALFA-2A (40KD) WITH OR WITHOUT LAMIVUDINE: RESULTS OF 4-YEAR FOLLOW-UP
- (2008) P. Marcellin et al. JOURNAL OF HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started